ZA923492B - Urapidil slow-release preparation - Google Patents

Urapidil slow-release preparation

Info

Publication number
ZA923492B
ZA923492B ZA923492A ZA923492A ZA923492B ZA 923492 B ZA923492 B ZA 923492B ZA 923492 A ZA923492 A ZA 923492A ZA 923492 A ZA923492 A ZA 923492A ZA 923492 B ZA923492 B ZA 923492B
Authority
ZA
South Africa
Prior art keywords
urapidil
slow
adjuvants
formulations
release preparation
Prior art date
Application number
ZA923492A
Inventor
Gerald Benedikt
Benedikt Gerald
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Priority to ZA923492A priority Critical patent/ZA923492B/en
Publication of ZA923492B publication Critical patent/ZA923492B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Abstract

Described is a retarded-action formulation for urapidil, based on the principle of osmotic action, in which the active substance, together with adjuvants, is enclosed in a semi-permeable envelope with an outlet hole. The formulation is characterized in that it contains a readily soluble salt of urapidil as the active substance, plus sugars and/or sugar alcohols with a solubility of less than 30 % by wt. in water at 37 DEG C as adjuvants. Formulations of readily soluble urapidil salts can be prepared for once-daily or twice-daily administration, these formulations being characterized above all by a high bioavailability which is unaffected by the intake of food.
ZA923492A 1990-11-27 1992-05-14 Urapidil slow-release preparation ZA923492B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA923492A ZA923492B (en) 1990-11-27 1992-05-14 Urapidil slow-release preparation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH376390 1990-11-27
ZA923492A ZA923492B (en) 1990-11-27 1992-05-14 Urapidil slow-release preparation
CN92103927A CN1079147A (en) 1990-11-27 1992-05-23 Urapidil slow-release preparation

Publications (1)

Publication Number Publication Date
ZA923492B true ZA923492B (en) 1992-12-30

Family

ID=25693784

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923492A ZA923492B (en) 1990-11-27 1992-05-14 Urapidil slow-release preparation

Country Status (10)

Country Link
EP (1) EP0559702B1 (en)
CN (1) CN1079147A (en)
AT (1) ATE116133T1 (en)
AU (1) AU8941491A (en)
DE (2) DE59104100D1 (en)
DK (1) DK0559702T3 (en)
ES (1) ES2069317T3 (en)
GR (1) GR3015176T3 (en)
WO (1) WO1992009273A1 (en)
ZA (1) ZA923492B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME01239B (en) 2007-02-01 2013-06-20 Takeda Pharmaceuticals Co Solid preparation comprising alogliptin and pioglitazone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form

Also Published As

Publication number Publication date
ES2069317T3 (en) 1995-05-01
DK0559702T3 (en) 1995-05-15
GR3015176T3 (en) 1995-05-31
WO1992009273A1 (en) 1992-06-11
EP0559702A1 (en) 1993-09-15
CN1079147A (en) 1993-12-08
EP0559702B1 (en) 1994-12-28
DE4193036D2 (en) 1996-06-27
AU8941491A (en) 1992-06-25
DE59104100D1 (en) 1995-02-09
ATE116133T1 (en) 1995-01-15

Similar Documents

Publication Publication Date Title
ES2039264T3 (en) AQUEOUS OR PULVERULENT PREPARATION, WATER DISPERSIBLE OF A PHARMACEUTICALLY ACTIVE PRODUCT DIFFICULTLY SOLUBLE IN WATER AND PROCEDURE FOR ITS OBTAINING.
JPS5758876A (en) Germicide for food, raw ingredient of food, and device for processing food, and its use
CA1139768A (en) Mixed salts of essential or semi-essential amino acids and nitrogen-free analogues thereof and uses in treatment of renal and hepatic disorders
PT742714E (en) LIQUID PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THYROID HORMONES
SE7903817L (en) MORANOLIN DERIVATIVES
SE9203744L (en) PROCEDURES FOR PREPARING A PHARMACEUTICAL COMPOSITION SELECTIVELY LOWING THE LIPID LEVEL OF BLOOD
ES2041616T1 (en) PROCEDURE TO PRODUCE BIOACTIVE PRODUCTS DERIVED FROM THE PEAT.
AU564166B2 (en) Protracted release microbiocidal articles
JPS5356315A (en) Emulsified solution of fat soluble drugs
EP0189377A3 (en) An agricultural composition with reduced toxicity to fishes and shellfishes
DE68901014D1 (en) ANTI-INFLAMMATORY-PROTECTED IBUPROFEN, WHICH DOES NOT HAVE BITTER TASTE, NO THROAT, AND NO INTESTINAL TOXICITY IN AQUEOUS SOLUTION.
SE311208B (en)
ZA923492B (en) Urapidil slow-release preparation
JPS57146722A (en) Pharmaceutical preparation having improved absorption
Selye Induced hypersensitivity to cold
JPS5762218A (en) Ophthalmic solution
JPS57156412A (en) Preparation containing dextromethorphan hydrobromide
HU896426D0 (en) Process for the preparation of aquous solutions of doxorubicin
IE38235B1 (en) Preparations for combatting swine dysentery
EP1046345A3 (en) Preparation for administration to animals and feeding method thereof
EP0389773A3 (en) Process for preparing a galenic formulation of 2-hydroxy-5-methyllaurophenonoxime with optimal bioavailability
Mitoma et al. Fate of water-insoluble and water-soluble dichlorozbenzidine-based pigments in Fischer 344 rats.
JPS5780317A (en) Preparation of pharmaceutical composition for injection
TH1788A (en)
JPS57118510A (en) Method of increasing absorption of membrane-absorptive preparation on administration